Search details
1.
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Nat Immunol
; 23(10): 1495-1506, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36151395
2.
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.
Immunity
; 54(3): 571-585.e6, 2021 03 09.
Article
in English
| MEDLINE | ID: mdl-33497609
3.
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
Nature
; 622(7984): 850-862, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37794185
4.
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Nature
; 595(7866): 309-314, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33953401
5.
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma.
Cancer Discov
; 12(3): 812-835, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34848557
Results
1 -
5
de 5
1
Next >
>>